Omalizumab and dyspnoea Patient Reports February 11, 2012
Omalizumab Side Effects Report #5756175-5
Omalizumab side effect was reported by a Physician from SWITZERLAND on Nov 15, 2007. Male patient, 54 years of age, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: anaphylactic reaction, angioedema, asthma
, dyspnoea. Omalizumab dosage: unknown. Patient recovered.Omalizumab Side Effects Report #5535764-7
Omalizumab side effect was reported by a Pharmacist from UNITED STATES on Dec 03, 2007. Male patient, 49 years of age, weighting 249.1 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dizziness
, dysphagia, dyspnoea, erythema, throat tightness. Omalizumab dosage: 225MG OTHER SQ. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #5451247-7
Omalizumab side effect was reported by a Pharmacist from UNITED STATES on Sept 11, 2007. Female patient, 36 years of age, weighting 132.3 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, face oedema, urticaria, wheezing. Omalizumab dosage: 300 MG Q4WK SQ. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #5356064-4
Omalizumab side effect was reported by a Physician from UNITED STATES on June 08, 2007. Female patient, weighting 165.3 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chest discomfort, dyspnoea, pharyngeal oedema. Omalizumab dosage: unknown. During the same period patient was treated with BENADRYL, PULMICORT, ALBUTEROL, PROTOPIC, TEMAZEPAM, ANTIHYPERTENSIVE, PREMARIN, QUININE SULPHATE. Patient recovered.Omalizumab Side Effects Report #5365425-9
Omalizumab side effect was reported by a Physician from SWITZERLAND on June 08, 2007. Female patient was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, headache
, oedema peripheral. Omalizumab dosage: 1.8 ML, Q2W. During the same period patient was treated with BUDESONIDE. Patient died on 05/16/2004.Omalizumab Side Effects Report #5418399-6
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Aug 09, 2007. Female patient was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, dyspnoea. Omalizumab dosage: unknown. During the same period patient was treated with AVELOX. Patient recovered.Omalizumab Side Effects Report #5602334-1
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 15, 2008. Male patient, weighting 165.3 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dysgeusia, dyspnoea, hypertension, sinus congestion. Omalizumab dosage: unknown. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #5614526-6
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 29, 2008. Female patient, weighting 213.8 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: asthma
, dyspnoea, hypersensitivity, pruritus. Omalizumab dosage: 300 MG, 1/MONTH. During the same period patient was treated with SYMBICORT, SINGULAIR. Patient recovered.Omalizumab Side Effects Report #5631414-X
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Feb 15, 2008. Male patient, weighting 165.3 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, hypertension, sinus congestion. Omalizumab dosage: unknown. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #5705635-1
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Mar 31, 2008. Male patient, weighting 185.2 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dysgeusia, dyspnoea, palpitations, pharyngeal oedema. Omalizumab dosage: 300 MG, Q4W. Patient recovered.Omalizumab Side Effects Report #5715184-2
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Apr 08, 2008. Female patient, weighting 97.89 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, swollen tongue. Omalizumab dosage: 150 MG, 1/MONTH. During the same period patient was treated with OXYGEN, EPIPEN. Patient recovered.Omalizumab Side Effects Report #5718633-9
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Apr 10, 2008. Female patient, weighting 138.9 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, eye oedema, hypotension. Omalizumab dosage: 150 MG, 1/MONTH. Patient recovered.Omalizumab Side Effects Report #5736869-8
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Apr 28, 2008. Male patient, weighting 185.2 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dysgeusia, dyspnoea, palpitations, pharyngeal oedema. Omalizumab dosage: 300 MG, Q4W. Patient recovered.Omalizumab Side Effects Report #5766368-9
Omalizumab side effect was reported by a Physician from CANADA on May 27, 2008. Male patient, weighting 185.2 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dysgeusia, dyspnoea, palpitations, pharyngeal oedema. Omalizumab dosage: 300 MG, Q4W. During the same period patient was treated with LOSEC I, VENTOLIN, FLONASE, FLOMAX, NORVASC, OXEZE, NEURONTIN, CALCIUM. Patient recovered.Omalizumab Side Effects Report #5879826-3
Omalizumab side effect was reported by a Physician from UNITED STATES on Sept 05, 2008. Female patient, weighting 153.2 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: anaphylactic reaction, chest discomfort, dyspnoea, pharyngeal oedema. Omalizumab dosage: unknown. During the same period patient was treated with BENADRYL, PULMICORT, ALBUTEROL, PROTOPIC, TEMAZEPAM, ANTIHYPERTENSIVE, PREMARIN, QUININE. Patient recovered.Omalizumab Side Effects Report #6004784-0
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Dec 01, 2008. Female patient, weighting 213.8 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea. Omalizumab dosage: 300 MG, UNK. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #6056012-8
Omalizumab side effect was reported by a Consumer or non-health professional from SWITZERLAND on Jan 15, 2009. Female patient, weighting 213.8 lb, was diagnosed with asthma
and was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, rash
. Omalizumab dosage: 300 MG, UNK. Patient was hospitalized. Patient recovered.Omalizumab Side Effects Report #5813383-2
Omalizumab side effect was reported by a Pharmacist from UNITED STATES on July 16, 2008. Female patient, 46 years of age, was treated with Omalizumab. After drug was administered, patient experienced the following side effects: dyspnoea, wheezing. Omalizumab dosage: unknown. Patient was hospitalized. Patient recovered.
Omalizumab and dyspnoea 